FDA Reviews New Data on Anemia Drugs:
What are erythropoietin drugs?
Mayo Clinic
Expert Summary
FDA is reviewing new data on a class of anemia drugs called erythropoietin, or ESA. Find out how these drugs work and why they could be dangerous.
Irina Ostrovsky-Day
Expert Scorecard
Overall Expert Score
Community Reviews
Overall Community Rating:
(0 reviews)
Add your rating:
click to select